600588:SSEYonyou Network Technology Co. Ltd. Class A Analysis
Data as of 2026-07-22 - not real-time
CN¥9.63
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Yonyou’s share price of 9.63 CNY sits just above its 20‑day SMA (9.25) but remains below the 50‑day (10.10) and 200‑day (12.92) averages, underscoring a bearish medium‑term trend. The RSI at 51 is neutral, while the MACD line is marginally above its signal, giving a slightly bullish histogram hint. Trading volume is on the rise, yet the 30‑day volatility of 44% signals a highly turbulent price environment. A DCF‑derived fair value of roughly 6.0 CNY versus the current 9.6 CNY price points to a significant overvaluation. Forward PE stands at 43.8×, well above the industry average of 33.8×, reinforcing the valuation concern. Revenue grew 6% year‑on‑year, but operating margins are deeply negative (‑47%) and the company posted a loss per share of –0.41 CNY. Despite positive operating cash flow, total debt (4.09 bn CNY) exceeds cash reserves, yielding a debt‑to‑equity ratio of 48% and a negative ROE. No dividend is paid, eliminating income‑return expectations. The Fear & Greed Index at 90.98 reflects “Extreme Greed,” suggesting market enthusiasm may be outpacing fundamentals. Overall, technical signals are mixed, fundamentals remain weak, and valuation is stretched, warranting a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price above 20‑day SMA but below longer‑term averages
- High short‑term volatility and extreme market greed
- Overvaluation relative to DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Modest revenue growth with improving forward EPS
- Persistent operating losses and high leverage
- Valuation still above peers despite cash‑flow positivity
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Continued overvaluation versus intrinsic worth
- Negative profitability metrics and debt burden
- Lack of dividend and uncertain turnaround timeline
Key Metrics & Analysis
Financial Health
Revenue Growth5.90%
Profit Margin-14.85%
P/E Ratio43.8
ROE-15.28%
ROA-3.83%
Debt/Equity48.10
P/B Ratio4.8
Op. Cash FlowCN¥829.8M
Free Cash FlowCN¥1.3B
Industry P/E33.8
Technical Analysis
TrendBearish
RSI51.2
SupportCN¥8.73
ResistanceCN¥10.10
MA 20CN¥9.25
MA 50CN¥10.10
MA 200CN¥12.92
MACDBullish
VolumeIncreasing
Fear & Greed Index90.98
Valuation
Fair ValueCN¥6.02
GradeOvervalued
TypeValue
Risk Assessment
Beta0.41
Volatility44.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.